Oct 23, 2026
5:4
For every 4 shares held, investors received 5. The price per share adjusted from $417.15 to $333.72.
The split itself did not change the total investment value.
Titan Biotech Limited (BSE:TITANBIO) operates in the Biotechnology industry.
Titan Biotech Limited company overviewTitan Biotech Limited's most recent stock split was on October 23, 2026. It was a 5-for-4 forward split, so shareholders received 5 shares for every 4 they held.
Titan Biotech Limited (BSE:TITANBIO) has split its stock 2 times: a 5-for-1 split on February 20, 2026 and a 5-for-4 split on October 23, 2026.
Titan Biotech Limited has split its stock 2 times. This history records 2 forward splits between February 20, 2026 and October 23, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Titan Biotech Limited's 5-for-4 split on October 23, 2026, every 4 shares became 5 shares.
Titan Biotech Limited has not announced a new split in our records. Its most recent split was on October 23, 2026, less than a year ago. Companies announce splits in advance, and any new BSE:TITANBIO split will appear on this page.
Already premium?